Immunotation of Rv2753c (dihydrodipicolinate synthase)
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
Line 45: | Line 45: | ||
=Bacterial Toxin= | =Bacterial Toxin= | ||
=External Links= | =External Links= | ||
- | + | <!--Categories--> | |
- | [[Category: | + | [[Category:DNA| ]] |
- | [[Category: | + | [[Category:Genetics]] |
- | [[Category: | + | [[Category:Helices]] |
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 09:19, 9 December 2009
Immunotation of Rv2753c (dihydrodipicolinate synthase)
| |
Systematic (IUPAC) name | |
(8R,9S,10R,13S,14S,17S)- 17-hydroxy-10,13-dimethyl- 1,2,6,7,8,9,11,12,14,15,16,17- dodecahydrocyclopenta[a] phenanthren-3-one | |
Identifiers | |
CAS number | 57-85-2 (propionate ester) |
ATC code | ? |
PubChem | |
DrugBank | |
ChemSpider | |
Chemical data | |
Formula | C19H28O2 |
Mol. mass | 288.42 |
SMILES | & |
Physical data | |
Melt. point | 1550deg C EXP °C |
Solubility in water | 23.4 mg/L at 250C EXP mg/mL |
Spec. rot | +110,2° |
SEC Combust | −11080 kJ/mol |
Pharmacokinetic data | |
Bioavailability | low (due to extensive first pass metabolism) |
Metabolism | Liver, Testis and Prostate |
Half life | 2-4 hours |
Excretion | Urine (90%), feces (6%) |
Therapeutic considerations | |
Pregnancy cat. |
X (USA), Teratogenic effects |
Legal status | |
Routes | Intramuscular injection, transdermal (cream, gel, or patch), sub-'Q' pellet |
Contents |